Menu Close

Cryoport Partners with World Courier to Provide Best-In-Class Logistics Platform for Global Cell and Gene Therapy Market

Cryoport, Inc. (NASDAQ: CYRX, CYRXW) (“Company”), today announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport’s full suite of temperature-controlled solutions into its global network. Integrated platform offers complete …

Date : 2018-07-17T05:01:00.000Z
Source :

Nohla Therapeutics Receives FDA Orphan Drug Designation for Dilanubicel for Hematopoietic Stem Cell Transplant Patients

“Dilanubicel has shown encouraging initial activity as a novel cell therapy in patients with hematologic malignancies receiving a cord blood transplant,” said Katie Fanning, President and CEO of Nohla Therapeutics. “We believe the addition of …

뉴스 수집 시각 : 2018-07-16T18:19:00.000Z
뉴스 본문 보기 :